Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Lack of association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in Brazilian prostate cancer patients.

Lima MM Jr, Oliveira MN, Granja F, Trindade AC, De Castro Santos LE, Ward LS.

Folia Biol (Praha). 2008;54(3):102-8.

2.

Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants.

Bufalo NE, Leite JL, Guilhen AC, Morari EC, Granja F, Assumpcao LV, Ward LS.

Endocr Relat Cancer. 2006 Dec;13(4):1185-93.

PMID:
17158763
3.

Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population.

Silig Y, Pinarbasi H, Günes S, Ayan S, Bagci H, Cetinkaya O.

Cancer Invest. 2006 Feb;24(1):41-5.

PMID:
16466991
4.

Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men.

Li M, Guan TY, Li Y, Na YQ.

Chin Med J (Engl). 2008 Feb 20;121(4):305-8.

PMID:
18304461
5.

Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population.

Honma HN, De Capitani EM, Perroud MW Jr, Barbeiro AS, Toro IF, Costa DB, Lima CS, Zambon L.

Lung Cancer. 2008 Aug;61(2):152-62. doi: 10.1016/j.lungcan.2007.12.014. Epub 2008 Feb 14.

PMID:
18280004
6.

Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people.

Acevedo C, Opazo JL, Huidobro C, Cabezas J, Iturrieta J, Quiñones Sepúlveda L.

Prostate. 2003 Oct 1;57(2):111-7.

PMID:
12949934
7.

Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.

Duarte EC, Ribeiro DC, Gomez MV, Ramos-Jorge ML, Gomez RS.

Anticancer Res. 2008 Mar-Apr;28(2A):1101-6.

8.

Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.

Chacko P, Joseph T, Mathew BS, Rajan B, Pillai MR.

Mutat Res. 2005 Mar 7;581(1-2):153-63. Epub 2005 Jan 18.

PMID:
15725614
9.

CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population.

Aktas D, Hascicek M, Sozen S, Ozen H, Tuncbilek E.

Cancer Genet Cytogenet. 2004 Oct 1;154(1):81-5.

PMID:
15381379
10.

Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease.

Bufalo NE, Santos RB, Cury AN, Andrade RA, Morari J, Morari EC, Leite JL, Monte O, Romaldini JH, Ward LS.

Clin Endocrinol (Oxf). 2008 Jun;68(6):982-7. Epub 2007 Nov 2.

PMID:
17980001
11.

Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.

Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, Madhavan J, Ankathil R.

J Exp Ther Oncol. 2008;7(1):73-85.

PMID:
18472644
12.

Polymorphisms of GSTP1 and related genes and prostate cancer risk.

Beer TM, Evans AJ, Hough KM, Lowe BA, McWilliams JE, Henner WD.

Prostate Cancer Prostatic Dis. 2002;5(1):22-7.

13.

[Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].

Fan CH, Jin MJ, Zhang Y, Song L, Xu H, Jiang QT, Yu WP, Chen K.

Zhonghua Yu Fang Yi Xue Za Zhi. 2006 Jan;40(1):13-7. Chinese.

PMID:
16620591
14.
15.

GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.

Manfredi S, Federici C, Picano E, Botto N, Rizza A, Andreassi MG.

Mutat Res. 2007 Aug 1;621(1-2):106-12. Epub 2007 Mar 2.

PMID:
17408703
16.

CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions.

Vineis P, Veglia F, Anttila S, Benhamou S, Clapper ML, Dolzan V, Ryberg D, Hirvonen A, Kremers P, Le Marchand L, Pastorelli R, Rannug A, Romkes M, Schoket B, Strange RC, Garte S, Taioli E.

Biomarkers. 2004 May-Jun;9(3):298-305.

PMID:
15764294
17.

CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations.

Lee KM, Kang D, Clapper ML, Ingelman-Sundberg M, Ono-Kihara M, Kiyohara C, Min S, Lan Q, Le Marchand L, Lin P, Lung ML, Pinarbasi H, Pisani P, Srivatanakul P, Seow A, Sugimura H, Tokudome S, Yokota J, Taioli E.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1120-6. doi: 10.1158/1055-9965.EPI-07-2786. Epub 2008 May 7.

18.

Lack of influence of glutathione S-transferase genotype profile on cancer susceptibility in smokers and nonsmokers.

Sampaio AC, Morari EC, Bufalo NE, Leite JL, Lima CS, Ward LS.

Med Sci Monit. 2009 Jan;15(1):CR10-5.

PMID:
19114965
19.

Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.

Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN, Parmar D.

Mutat Res. 2008 Mar 1;639(1-2):1-10. Epub 2007 Oct 30.

PMID:
18082227
20.

Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study.

Quiñones LA, Irarrázabal CE, Rojas CR, Orellana CE, Acevedo C, Huidobro C, Varela NE, Cáceres DD.

Asian J Androl. 2006 May;8(3):349-55.

Supplemental Content

Support Center